Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
160 USD | -1.54% | -0.84% | +3.48% |
05:12pm | AbbVie Says Canadian Regulator Expands Qulipta Indication to Cover Chronic Migraine | MT |
04:08pm | Daiwa Securities Adjusts Price Target on AbbVie to $171 From $190 | MT |
- Stock Market
- Equities
- ABBV Stock
- News AbbVie Inc.